Session 2: Considerations in Program and Product Design
Session 3: Valuation and Subsidy Measures
Session 4: Credit Portfolio Costs and Managing Performance
Session 2: Considerations in Program and Product Design
Session 3: Valuation and Subsidy Measures
Session 4: Credit Portfolio Costs and Managing Performance
This introductory session provides an opportunity for participants to consider, more broadly, government involvement in the credit marketplace. Discussion centers on market failures that commonly lead to the creation of government credit programs and ways to identify and quantify mission objectives and program outcomes for the purpose of ensuring policy effectiveness.
Session 1 Slides: Introduction and Program Objectives (PDF)
Chart 1.1: Defining the Mission, the Market, Mission Success, and Agency Performance
Chart 1.2: How do we Know We’ve Suceeded?
Chart 1.3: How do we Minimize Risk and Costs While Maximizing Impact?
Chart 1.4: The Problem That Needs to be Solved
Chart 1.5: Examples of Products Created in Response
Chart 1.6: Map from TRF
Chart 1.7: The Relationship Between Objectives and Outcomes
Chart 1.8: Macro Indicators
Chart 1.9: Agency Specific (SBA Example)
Chart 1.10: Examples of Different Kinds of Lenders
Chart 1.11: Commercial Banks with Assets Greater than $3 Billion (EOY)
Chart 1.12: Metrics that Define the Asset
Chart Files: Charts for Session 1 (XLSX); Charts for Session 1 (PDF)
Providing financial aid or support with the aim of promoting economic and social policy entails subsidization, and that general concept is introduced in this session. Some missions require a larger federal footprint while others might benefit from more private involvement. There are five basic platform options for delivering intended subsidies and they are designed to be responsive to the distinction. Delivery platforms should be evaluated and compared in terms of structure, taxpayer risk and cost, magnitude of obligation, difficulty of management, need for partnership, level of control, extent of mission impact and other attributes – including whether the proposed credit product is suitable to the beneficiary. A range of decisions is associated with product design including: amount, rate, term, amortization, credit risk and demography. Finally, this session focuses on the functioning of the combined product and platform over time and considers metric adjustments to ensure the portfolio reflects market conditions. GCFP provides a proprietary calculator that incorporates the product design, delivery platform and program performance assumptions into a single set of forecasts for both the agency and its lending partners or grantees. Objective is to ensure delivery platform and product design minimize taxpayer risk/cost and maximize prospects for mission accomplishment.
Notion of subsidy since the very nature of government provision of credit entails some form of subsidization, regardless of expected costs
Session 2 Slides: Considerations in Program and Product Design (PDF)
Chart 2.1: How do we Minimize Risk and Costs While Maximizing Impact?
Chart 2.2: Calculation of the Benefits EX-IM Bank
Chart 2.3: Calculation of the Benfits of the SBA 7a
Chart 2.4: Calculation of the Benefits of the CDFI Fund NMTC
Chart 2.5: Why is There a Credit Gap?
Chart 2.6: Examples of Different Kinds of Lenders
Chart 2.7: “Quick and Dirty” Unit Cost Analysis
Chart 2.8: Product Delivery
Chart 2.9: Platform Type
Chart 2.10: Leveraging the Platform
Chart 2.11: BUT - Downside Risk
Chart 2.12 Downside Risk
Chart Files: Charts for Session 2 (XLSX); Charts for Session 2 (PDF)
Determining whether a particular government credit program is in the public interest requires a careful assessment of costs and benefits. A primary focus is the credit subsidy. This session aims to educate participants on the basic finance principles used to assess and forecast this cost. For illustrative purposes, the discussion will be based around an example of how each facet shows up in the planning process of one agency.
Session 3 Slides: Valuation and Subsidy Measures (PDF)
Charts for this session are not currently available.
Extending credit involves more than getting money out the door in a timely manner. There are widely used techniques and tools for managing credit portfolios efficiently and prudently, and also for measuring program effectiveness. In this session, focus is on the the information necessary for managing performance including the functions associated with extending credit, the costs, the range of choices in performing the functions and the benchmarking of performance. The session is not about Information Technology, but rather how to think about the dynamics of credit-related activities. From the standpoint of the agency budget, such activities are generally funded out of the administrative budget. Session also includes an overview of methods for identifying, assessing and managing credit risk. Finally, this session addresses the metrics that can be used to identify program impact and effectiveness. Together such metrics provide a general basis for performing program cost-benefit analysis.
There are seven basic functions in the extension of credit: Marketing, origination, underwriting, closing, servicing, monitoring and exit. This session explores:
In order to assess risk in a portfolio, program manager relies on a well-defined set of definitions, risk assessment tools and reporting protocols.
Key metrics in portfolio management:
Session 4 Slides: Managing Operating Costs and Credit Risk (PDF)
Chart 4.1: The Seven Basic Functions for Extending Credit
Chart 4.2: Claculating Operating Costs by Function
Chart 4.3: The Unit Cost Analysis
Chart 4.4: Delegating, Outsourcing, and Sharing
Chart 4.5: Lowering Costs Through Techology Upgrades
Chart 4.6: What Kind of Risk Are we Supposed to be Preparing For?
Chart 4.7: Key Problem: The Loss Curve
Chart 4.8: Credit Scoring
Chart 4.9: Standard Definitions
Chart 4.10: Examples of Rating a Loan and Allocating Losses
Chart 4.11: Credit Audit
Chart 4.12: Key Operating Data Points
Chart 4.13: Key Credit Risk Data Points
Chart 4.14: Conversion Application for Comparative Analysis: From Credit Reform Calculations to Standard Institutional Reporting
Chart Files: Charts for Session 4 (XLSX); Charts for Session 4 (PDF)
This session explores how for-profit institutions approach the provision of credit. The purpose is to gain insights into their operations to enable government partnering agencies to better interface and protect taxpayer dollars in various public-private partnerships that can form to extend credit to borrowers.
Session 5 Slides: Working with Private Partners (PDF)
Chart 5.1: Anticipating and Accounting for Credit Losses
Chart 5.2: T-accounts for the Loss Reserve
Chart 5.3: Examples of Different Kinds of Lenders
Chart 5.4: Commercial Banks with Assets Greater than $3 Billion (EOY)
Chart 5.5: The Chief Focus and Related Strategies
Chart 5.6: A Successful Agency Solution: The SBA’s Parris System for Participating Lenders
Chart 5.7: The Neighborworks Prompt for Non-profit Development Corporations and CDFIS
Chart 5.8: Risk Indicators for a Small Non-depository Program Participant (Broker, Mortgage Banker, Asset-based Lender)
Chart 5.9: Agency Protocols and Procedures for Participating Lenders with Different Risk Ratings
Chart 5.10: Graduated Remedies for Participating Lenders with Poor Ratings
Chart 5.11: Quick Track of the Portfolio Trend and the Outliers
Chart Files: Charts for Session 5 (XLSX); Charts for Session 5 (PDF)
In this session participants break into groups to explore the creation of various hypothetical federal credit programs. Groups will consider mission and metrics including program design (e.g., market failure / rationale, objectives, structure), funding (e.g., taxpayer risk, subsidy BA, operating expenses), management (e.g., operate, monitor, measure impact, adjust) and sunset.
Policymakers are exploring the creation of a federal credit program to help people afford transformative therapies that cure potentially lethal conditions such as cancer or hepatitis C. Breakthrough hepatitis C drugs such as Sovaldi and Harvoni can cure people of the liver-destroying disease in a few months, but the price tag of $84,000 or more has led many insurers to limit coverage to people whose disease has significantly progressed to show signs of liver damage. In order to make such treatments more widely available, the government is considering the establishment of a program to increase the availability of funds for such drugs but would require that individuals who are cured would repay amounts provided, over time.
In anticipation of climate change (e.g., rising sea levels, erratic and severe weather patterns), policymakers are considering the creation of a loan program to help citizens and businesses relocate from high-risk areas that are particularly vulnerable to flooding or other adverse impacts from global warming. Staff have been asked to design a loan program to enable affordable relocation while keeping taxpayer costs at a minimum.
Given severe physical infrastructure needs across the US, policymakers are considering ways the federal government might support municipal governments to spur national infrastructure development and improvement. By providing bond insurance or support, costs to municipalities would fall, thereby increasing likelihood of such projects being funded. All options are being considered: Grants, loans, bond guaranties, credit enhancements and tax incentives—although the loan and loan guaranty options seem to have some initial support given expectations of low cost estimates.
Policymakers are exploring the creation of a program to allow state government to “rent” its full faith and credit designation to spur community development lending in distressed parts of the country. Unlike the federal government, state governments are generally prohibited by law from pledging their credit on behalf of private parties. Instead, state loan and loan guarantee programs are backed by dedicated reserve accounts. A new program would have the federal government play some role (e.g., capital provider, lender, guarantor) to stimulate the creation of state-level funds to fund small business creation / growth and other economic development projects.
Congress is considering legislation to establish an “Eye Bond” program to spur research and investment in the treatment and cure of ocular diseases. The initial program would focus on one category of disease and build within it a diversified portfolio of eligible projects just short of treating patients. Once the concept of attracting new, long term institutional investment funding for biomedical research, other treatments could be considered for funding in a similar fashion. Bond proceed would go to small labs, university researchers and other scientists struggling to take basic research to patients. The National Eye Institute, part of NIH, will select eligible projects. Government risk is initially limited to no more than $1 billion of bonds with no more than $250 million issued in any one year of five authorized for the program. The USG guarantee can apply to no more than 50% of the principal amount of bonds issued and cannot cover any of the interest payments. Bonds must be structured to give first priority to protecting the interests of taxpayers and all cash received from eye bond repayments must first be used to reduce the amount of USG guarantees. No guarantee shall be made unless an appropriation has been provided or the bond issuer makes a payment to the government for the full cost of the guarantee.
Policymakers are considering the establishment of a program to reduce funding costs for companies involved in the manufacture of zero-emission automobiles. A range of options is being considered where the federal government would play some role (e.g., capital provider, lender, bond or loan guarantor) to stimulate additional development and commercialization of green-car technologies.